Response of thymectomy: Clinical and pathological characteristics among seronegative and seropositive myasthenia gravis patients

Acta Neurologica Scandinavica

Volumn 109, Issue 3, 2004, Pages 217-221

  Guillermo, G R ^a   Tellez Zenteno J F ^a   Weder Cisneros, N ^a   Mimenza, A ^a   Estanol B ^a   Remes Troche, J M ^a   Cantu Brito, C ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Myasthenia gravis; Response; Seronegative; Seropositive; Thymectomy; Thymoma; Thymus histology

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DETERIORATION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MYASTHENIA GRAVIS; NEUROPATHOLOGY; OUTCOMES RESEARCH; POSTOPERATIVE PERIOD; REMISSION; THYMECTOMY; THYMUS;

ADULT; AUTOANTIBODIES; DISEASE PROGRESSION; EDROPHONIUM; ELECTROMYOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; NEUROLOGIC EXAMINATION; POSTOPERATIVE COMPLICATIONS; RECEPTORS, CHOLINERGIC; THYMECTOMY; THYMOMA; THYMUS HYPERPLASIA; THYMUS NEOPLASMS; TREATMENT OUTCOME;

EID: 1442349760     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2003.00209.x     Document Type: Article

References (28)

1. TELLEZ ZENTENO JF, MORALES BUENROSTRO LE, TORRE DELGADILLO A. Pathogenesis of myasthenia gravis. Rev Invest Clin 2000;52:78-83.
2. BLALOCK A, MASON MF, MORGAN HJ, RIVEN SS. Myasthenia gravis and tumors of the thymic region, report a case in wich tumor was removed. Ann Surg 1939;110:554-61.
3. DRACHMAN D. Myasthenia gravis. N Engl J Med 1994;330:1797-1810.
4. LEFVERT AK, BERGSTROM K, MATELL G, OSTERMAN PO, PIRSKANEN R. Determination of acetylcholine receptor antibody in myasthenia gravis; clinical usefulness and pathogenetic implications. J Neurol Neurosurg Psychiatry 1978;41:394-403.
5. LENNON V. Serologic profile of myasthenia gravis and distinction form the Lambert-estaon myasthenic syndrome. Neurology 1997;48:S23-7.
6. SOLIVEN BC, LANGE DJ, PENN AS et al. Seronegative myasthenia gravis. Neurology 1988;38:514-17.
7. HANKINS JR, MAYER RF, SATTERfIELD JR, TURNEY SZ, ATTAR S, SEQUEIRA AJ. Thymectomy for myasthenia gravis: 14 years experience. Ann Surg 1985;201:618-25.
8. PAPATESTAS AE, GENKINS G, KORNFELD P, EISENKRAFT JB, FAGERSTROM RP, POZNER J. Effects of thymectomy in myasthenia gravis. Ann Surg 1987;206:79-88.
9. VINCENT A, NEWSON-DAVIS J, NEWTON P, BEACK N. Acethilcholine receptor antibody and clinical response to thymectomi in myasthenia gravis. Neurology 1983;33:1276-82.
10. BERRIH S, EVELYNE M, GRAUD C, RAIMOND F, LEBRIGAND H, BACH JF. Anti-AChR antibodies, thymic histology, and dT cell subsets in myasthenia gravis. Neurology 1984;34:66-71.
11. EVOLI A, BARTOCCIONI E, BATOCCHI AP, SCUDDERI F, TONALI P. Anti-AchR-negative myasthenia gravis: clinical and immunological features. Clin Invest Med 1989;12:104-9.
12. LINSDTROM J. An assay for antibodies to human acetylcholine receptor receptor in serum from patients with myasthenia gravis. Clin Ummunol Ummunopathol 1977;7:36-43.
13. OGER J, KAUFMAN R, BERRY K. Acetylcholine receptor antibodies in myasthenia gravis: use of a quantitative assay for diagnostic purposes. Can J Neurol Sci 1987;14:297-302.
14. BESINGER UA, TOYKA KV, HOMBERG M, HEININGER K, HOHLFELD R, TATEH-MOGHADAM A. Myasthenia gravis; long term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptor with changes in disease severity. Neurology 1983;33:1316-21.
15. HOCH W, MCCOVILLE J, HELMS S, NEWSON-DAVIS J, MELMS A, VINCENT A. Auto-antibodies to the receptor tyrosine kinase MuSK, in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 2001;7:365-8.
16. TELLEZ-ZENTENO JF, REMMES-TROCHE JM, GARCÍA-RAMOS G, ESTAÑOL B, GARDUÑO-ESPINOZA J. Prognostic factors of thymectomy in patients with myasthenia gravis. A cohort of 132 patients. European Neurology 2001;46:171-7.
17. JARETZKI A, PENN A, YOUNGER D et al. "Maximal" thymectomy for myasthenia gravis. J Thorac Cardiovasc Surg 1988;95:747-57.
18. LINSTROM JM, SEYBOLD ME, LENNON VA, WHITTINGHAM S, DUANE DD. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology 1976;26:1054-9.
19. ANDREWS PI, MASSEY JM, SANDERS DB. Acetylcholine receptor antibodies in juvenile myasthenia gravis. Neurology 1993;43:977-82.
20. SANDERS D, ANDREWS I, HOWARD J, MASSEY J. Seronegative myasthenia gravis. Neurology 1997;48:S40-5.
21. HATTON P, DIEHL J, DALY B et al. Transsseternal radical thymectomy for myasthenia gravis; a 15-year review. Ann Thorac Surg 1988;47:438-40.
22. BUSCH C, MACHENS A, PICHLMEIER U, EMSKOTTER T, IZBICKI J. Long-term outcome and quality of life after thymectomy for myasthenia gravis. Annals Surg 1996;224:225-32.
23. FRIST W, THIRUMALAI S, DOEHRING C et al. Thymectomy for the myasthenia gravis patient: factors influencing outcome. J Neurol Neurosurg Psyciatry 1991;54:406-11.
24. GRONSETH G, BAROHN R. Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review). Neurology 2000;55:7-15.
25. VERMA P, OGER J. Seronegative generalized myasthenia gravis; low frequency of thymic pathology. Neurology 1992;45:586-9.
26. EVOLI A, BARTOCCIONI E, BATOCCHI AP, SCUDERI F, TONALI P. Anti-AchR-negative myasthenia gravis: clinical and immunological features. Clin Inves Med 1989;12:104-9.
27. BERRIH S, EVELYNE M, GAUD C, RAIMOND F, LEBRIGAND H, BACH JF. Anti-AchR antibodies, thymic histology, and T cell subsets in myasthenia gravis. Neurology 1984;34:66-71.
28. HOHLFELD R, WEKERLE H. The thymus in myasthenia gravis. Neurologic Clinics 1994;12:331-42.